This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Clean and dry the affected area and apply the cream. Wash your hands after applying, unless hands are the affected area.
Ultrabrite Cream is a combination of three medicines: Hydroquinone Topical, Mometasone Topical and Tretinoin Topical which treat melasma (dark spots on skin). Hydroquinone Topical is a skin lightening medicine. It reduces the amount of a skin pigment (melanin) that causes darkening of skin. Mometasone Topical is a steroid medicine. It blocks the production of certain chemical messengers (prostaglandins) that make the skin red, swollen and itchy. Tretinoin Topical is a form of vitamin A that helps the skin to renew itself more quickly.
Ultrabrite Cream may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Ultrabrite Cream is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby. The baby's skin should not come into direct contact with the treated area of skin. Water-miscible cream/gel is preferred as ointments may expose the baby to harmful effects of Ultrabrite Cream via licking.
What were the side-effects while using Ultrabrite Cream?
No Side Effect
How do you take Ultrabrite Cream?
With or without food
How much was the improvement?
Please rate Ultrabrite Cream on price
What are you using Ultrabrite Cream for?
Melasma (Dark and discolored patches on the skin)
Hyperpigmentation (Dark skin patches)
Survey Participants: 64
“The following are the results of on-going survey on 1mg.com for Ultrabrite Cream. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 24th Apr 2017.